Stock SYNERGY PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Synergy Pharmaceuticals Inc Nasdaq

Equities

US8716393082

Biotechnology & Medical Research

Business Summary

Synergy Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of novel gastrointestinal (GI) therapies. Its gastrointestinal (GI) platform is based on uroguanylin. Uroguanylin physiologically regulates bowel function, fluid balance, and stool consistency.

Managers

Managers TitleAgeSince
Stephen Comiskey PRN
 Corporate Officer/Principal - 08-06-30
Leslie M. Magnus PRN
 Corporate Officer/Principal - 14-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 248,037,301 247,325,270 ( 99.71 %) 0 99.71 %

Company contact information

Synergy Pharmaceuticals LLC

420 Lexington Avenue Suite 2012

10170, New York

+212-297-0020

http://www.synergypharma.com
address Synergy Pharmaceuticals Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Company Synergy Pharmaceuticals Inc